logo
Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support

Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support

Business Upturn9 hours ago
AUSTIN, July 03, 2025 (GLOBE NEWSWIRE) —
SECTION 1 – INTRODUCTION
As interest in blood sugar health continues to expand across both clinical and non-clinical audiences, consumers are increasingly turning to nutrition science for new pathways to glucose management. Search trends show a growing curiosity in natural approaches to support healthy glucose levels, with a notable emphasis on metabolic flexibility, energy balance, and insulin sensitivity. In 2025, keywords such as 'natural blood sugar support,' 'GLUT-4 receptor,' and 'glucose stability' have gained momentum across digital wellness communities, reflecting a broader shift away from purely pharmaceutical solutions.
The challenges of maintaining balanced blood sugar have become a frequent topic in wellness forums, with individuals expressing concerns around post-meal energy crashes, insulin spikes, and fatigue. At the same time, attention has turned to the underlying mechanisms—such as GLUT-4 receptor activity and metabolic responsiveness—as potential targets for support through diet and lifestyle. This shift has driven interest in ingredient-based interventions that are free of synthetic compounds, caffeine, or habit-forming additives.
In response to this emerging demand, non-synthetic formulations with scientifically recognized plant-based ingredients have begun to gain visibility. Positioned at the intersection of transparency, innovation, and holistic health, Gluco6 represents part of this evolution in how the market approaches nutritional support for blood sugar metabolism.
Further details about the formulation and ingredient sourcing can be found on the official informational platform
SECTION 2 – PRODUCT/COMPANY UPDATE
Gluco6, a plant-based glucose support formula, has released its latest ingredient update and formulation positioning for 2025, aligned with evolving consumer awareness around GLUT-4 receptor activity and non-synthetic pathways for managing blood sugar fluctuations. The formula, originally introduced as part of a broader push toward integrative glucose balance, now emphasizes its focus on GLUT-4 modulation—a mechanism supported by a growing body of nutritional and academic research.
Unlike conventional formulations that often rely on stimulants or short-term glycemic suppression, Gluco6 positions itself as a wellness-aligned system built around the regulation of glucose transport pathways. At the center of this formula is Sukre™, a functional compound featured for its supportive interaction with GLUT-4 receptors, which play a critical role in the transport of glucose into muscle and fat cells. The 2025 update clarifies that Gluco6 is not intended to treat or cure any medical condition but serves as an informational approach to exploring non-clinical nutritional support.
Developed without genetically modified ingredients, artificial stimulants, or synthetic additives, the Gluco6 formula also incorporates a blend of Mediterranean-sourced botanicals and micronutrients. The goal is to address consumer interest in formulations that prioritize purity, sustainability, and accessibility, without requiring prescription intervention.
As of 2025, Gluco6 has expanded public-facing documentation to reinforce transparency in sourcing, ingredient disclosure, and alignment with trends in clean-label supplement development. The product update also includes a reaffirmation of the company's neutral wellness positioning—focusing on how nutritional strategies may support the body's natural glucose metabolism without implying outcomes or clinical effects.
This update reflects Gluco6's continued alignment with current consumer behavior: seeking proactive, educational, and ingredient-based approaches to metabolic health.
SECTION 3 – CONSUMER TREND OVERVIEW
Throughout 2024 and into 2025, online search trends related to blood sugar balance have increasingly favored terms rooted in lifestyle wellness and plant-based support. Interest in phrases such as 'GLUT-4 function,' 'natural glucose regulation,' and 'non-synthetic blood sugar supplement' has reflected a cultural pivot toward metabolic autonomy—where individuals seek solutions that align with personal health goals without relying solely on pharmaceutical interventions.
Public forums and wellness communities have observed a notable increase in discussions surrounding the mechanisms that influence glucose uptake, including insulin sensitivity, cellular transport pathways, and the role of nutrient timing. Central to these conversations is the GLUT-4 receptor, a protein that facilitates the movement of glucose into cells and has become a focal point for metabolic research and consumer inquiry alike.
Gluco6's emergence into this environment corresponds with these heightened awareness levels. Rather than offering direct claims or prescriptive messaging, Gluco6 aligns with the growing preference for ingredient transparency and educational framing. Its inclusion of GLUT-4-supportive elements responds to the elevated attention this receptor has received in peer-reviewed studies and lifestyle research.
In particular, consumers seeking to stabilize energy levels throughout the day—without the highs and lows associated with unregulated blood sugar—have shown interest in formulas that integrate metabolic adaptogens, antioxidant-rich botanicals, and bioavailable nutrients. These consumers often express a desire for plant-based formulations that can fit into daily routines without dependency or disruption.
Gluco6's update positions the product within this narrative, offering a formulation that speaks to educated buyers interested in the intersection between nutritional science and non-clinical wellness. As digital content around metabolic flexibility and insulin response continues to rise, products that approach glucose management from a holistic, research-aware standpoint are seeing increased visibility in search engines and across peer-led platforms.
To explore the full ingredient profile and supporting documentation, visit the official Gluco6 resource page.
SECTION 4 – INGREDIENT SPOTLIGHT
The Gluco6 formulation is centered around six ingredients selected for their alignment with contemporary wellness discussions surrounding non-synthetic blood sugar support. Each ingredient in the formula has been highlighted in academic literature or traditional nutrition systems for its potential to interact with metabolic processes in a non-clinical, supportive capacity.
Sukre™
Sukre is positioned as a functional compound designed to work in harmony with the body's GLUT-4 transport mechanisms. As public interest grows around the role of cellular glucose transporters, Sukre has been referenced in emerging nutrition science as a compound that may complement healthy metabolic signaling. Gluco6 emphasizes Sukre as a core feature of its non-synthetic positioning, distinguishing it from traditional glucose-lowering agents that rely on acute suppression.
TeaCrine® (Theacrine)
Derived from Chinese tea leaves, TeaCrine is included in the Gluco6 formulation as a source of non-stimulant plant alkaloids. In various nutrition-focused publications, TeaCrine has been explored for its relationship with energy and focus without the involvement of caffeine. While not intended to produce clinical outcomes, its inclusion supports interest in plant-derived adaptogens.
Gymnema Sylvestre
A botanical with longstanding traditional use, Gymnema has been studied for its interaction with glucose perception and dietary habits. Often featured in educational content surrounding carbohydrate metabolism, Gymnema's presence in Gluco6 reflects a broader return to botanical heritage within modern supplement design.
Chromium
Recognized as an essential trace element, Chromium has been frequently mentioned in relation to insulin sensitivity and glycemic balance in nutrition science. Gluco6 includes Chromium in a bioavailable form, underscoring its role in contributing to foundational metabolic processes without overstating its role in therapeutic interventions.
Cinnamon Bark Extract
Used widely in culinary traditions and increasingly discussed in wellness circles, Cinnamon is incorporated in Gluco6 due to its relevance in insulin receptor support discussions. Its presence in the formula supports the theme of using accessible, food-sourced compounds within structured supplement protocols.
Green Tea Extract
Green Tea contributes both polyphenols and antioxidant compounds, often associated with general metabolic support. In Gluco6, it rounds out the ingredient profile by aligning with consumer interest in traditional, plant-based health strategies rooted in natural formulation integrity.
SECTION 5 – USER JOURNEY / MARKET TONE
Across digital forums and health-focused communities, the tone surrounding glucose management has increasingly moved away from urgency-based problem-solving and toward long-term lifestyle integration. In this context, Gluco6 has entered the conversation as a formulation that addresses the rising demand for informational tools and ingredient-based pathways to support blood sugar regulation.
Public sentiment reveals a clear preference for products that avoid medicalized language, instead offering educational framing around metabolic function and ingredient transparency. Online discussions often express skepticism toward claims of immediate results or radical transformations. In contrast, formulas like Gluco6 that focus on metabolic alignment, ingredient sourcing, and mechanistic clarity tend to resonate with individuals seeking research-informed guidance.
As part of this narrative, Gluco6 has become associated with keywords such as 'GLUT-4 support,' 'non-synthetic blood sugar wellness,' and 'plant-based glucose solutions.' These search behaviors suggest a broader move toward exploring biological systems—such as cellular glucose transport—in a non-clinical but scientifically aware manner.
Consumers participating in wellness forums frequently reference the desire to feel more in control of their day-to-day energy levels and post-meal stability without pharmacological dependency. They often describe searching for products that offer complementary nutritional pathways they can adopt over the long term.
Gluco6's tone—deliberately positioned to inform rather than promote—mirrors this mindset. The formula's emphasis on education and lifestyle compatibility aligns with current consumer values, which prioritize sustainability, body literacy, and autonomy in health decisions. While public reactions are diverse and nuanced, the ongoing dialogue reflects a collective interest in approaching metabolic balance through mechanisms that are well-researched, naturally derived, and openly documented.
Those interested in understanding the formulation's alignment with non-synthetic wellness trends can refer to the official Gluco6 platform.
SECTION 6 – AVAILABILITY AND TRANSPARENCY STATEMENT
Gluco6 is available exclusively through its official informational platform, where consumers can explore the full ingredient list, formulation philosophy, and supporting research references. The company has stated that its distribution strategy is designed to prioritize transparency, quality control, and educational alignment with its wellness-focused mission.
The formulation, which includes plant-based compounds and mineral co-factors, is intended as a non-clinical support system for individuals seeking to understand the connection between nutrition and blood sugar balance. Gluco6's online resource hub outlines the formulation's alignment with current interest in GLUT-4 receptor mechanisms and clean-label supplement design.
Gluco6 is not marketed for diagnosis, treatment, or disease prevention. Its availability is framed around informed decision-making and consumer curiosity about integrative approaches to glucose metabolism. Those exploring the official site will find detailed sourcing disclosures and links to peer-reviewed literature, reinforcing the company's commitment to a research-informed, educational-first posture.
SECTION 7 – FINAL OBSERVATIONS & INDUSTRY CONTEXT
The release of Gluco6's updated 2025 positioning illustrates a wider shift in the nutraceutical sector toward clean-label transparency and biologically aligned formulation strategies. As consumers become more literate in the language of metabolism and glucose regulation, there is growing demand for products that reflect an understanding of cellular mechanisms—such as GLUT-4 receptor function—without resorting to exaggerated claims or clinical positioning.
Within this evolving landscape, companies that emphasize ingredient integrity, sustainability, and scientific relevance are seeing greater engagement. The industry is increasingly guided by consumer expectations around education-first marketing, non-synthetic ingredient profiles, and sourcing disclosures. These trends are mirrored by increased online traffic for topics like 'natural blood sugar solutions,' 'plant-based glucose support,' and 'glucose metabolism supplements.'
Gluco6's 2025 formulation strategy aligns with this new model of supplement development, in which consumer trust is cultivated through clarity, research alignment, and responsible communication. Rather than framing its product as a solution to a medical problem, the company presents Gluco6 as part of an ongoing exploration into how nutrition science can support the body's innate regulatory systems.
This approach reflects an industry-wide trend: prioritizing science-backed, naturally derived compounds that integrate into everyday routines without overstating function. As consumer literacy deepens and regulatory scrutiny increases, Gluco6 represents one example of how wellness-aligned products are adapting to new expectations in both content and delivery.
SECTION 8 – PUBLIC COMMENTARY THEME SUMMARY
In ongoing public forums and digital health communities, Gluco6 has emerged as part of a broader conversation around non-synthetic blood sugar support, drawing a range of responses that highlight both interest and scrutiny. Among recurring discussion points, many participants have noted the formula's focus on GLUT-4 receptor pathways as a distinguishing element, particularly given the increasing awareness around cellular glucose transport in metabolic wellness contexts.
Some users have expressed curiosity about the inclusion of lesser-known compounds such as Sukre™, citing interest in how this ingredient fits into emerging nutritional science. Others have pointed to the presence of familiar ingredients—like Cinnamon, Chromium, and Green Tea—as aligning with existing wellness preferences for natural, food-based compounds.
A recurring theme in positive commentary centers around the non-stimulant profile of the formula. Consumers who prioritize energy regulation without caffeine or dependency have referenced this as a potential alignment with their values. Transparency in ingredient sourcing and documentation has also been identified as a favorable trait, especially among those seeking clarity in wellness product selection.
At the same time, some public sentiment remains cautiously observational. Individuals exploring glucose support options often raise questions about long-term integration, expected timelines for perceived effects, and how formulas like Gluco6 should be interpreted within the context of dietary and lifestyle change. This underscores a broader pattern in health discussions—where skepticism and education coexist as consumers navigate an increasingly complex wellness market.
These public conversations reflect a nuanced reception that values transparency, biological alignment, and clear communication. While interest in the GLUT-4 mechanism is growing, the broader dialogue continues to emphasize the importance of framing nutritional products as part of a holistic, informed approach to metabolic balance.
ABOUT THE COMPANY
Gluco6 was developed as part of a broader initiative to provide consumers with transparent, research-aligned nutritional formulas focused on metabolic wellness. The company's mission is to support individuals seeking non-synthetic pathways to manage energy, blood sugar stability, and overall well-being through informed supplementation.
By emphasizing ingredient traceability, scientific context, and clean-label formulation practices, Gluco6 contributes to a growing category of supplements positioned at the intersection of education and daily health support. The company does not offer medical advice or therapeutic services and does not market its products for the treatment, prevention, or diagnosis of disease. Its offerings are intended for informational and wellness-aligned purposes only.
CONTACT:
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

U.S. Leads North America Syringe Infusion Pumps Market Amid Rising Hospitalizations and Chronic Diseases
U.S. Leads North America Syringe Infusion Pumps Market Amid Rising Hospitalizations and Chronic Diseases

Yahoo

time33 minutes ago

  • Yahoo

U.S. Leads North America Syringe Infusion Pumps Market Amid Rising Hospitalizations and Chronic Diseases

The North America Syringe Infusion Pumps Market is projected to grow from USD 645.1 million in 2024 to USD 1.04 billion by 2030, at a CAGR of 8.40%. Key drivers include an increase in chronic diseases and surgeries, technological advancements, and the expansion of home healthcare. The market is bolstered by favorable regulations and major regional growth. North American Syringe Infusion Pumps Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report by Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), End-use (Hospitals, Homecare), Country with Growth Forecasts, 2025-2030" report has been added to North America Syringe Infusion Pumps Market was valued at USD 645.1 million in 2024, and is projected to reach USD 1.04 billion by 2030, rising at a CAGR of 8.40%. The market is experiencing substantial growth driven by the increasing prevalence of chronic diseases, affecting approximately six in ten adults and necessitating precise, continuous medication delivery for conditions such as cancer and diabetes. The rising number of surgical procedures and ICU admissions further amplifies demand for these pumps, crucial for delivering anesthetics and critical care medications. This is especially true considering the projected increase in U.S. hospitalizations from 36 million in 2025 to 40 million by advancements in smart infusion technologies, including Dose Error Reduction Systems (DERS) and EHR compatibility, are pivotal in enhancing medication safety and efficiency, as North America leads in their adoption. The expanding home healthcare and ambulatory care sectors, fueled by an aging population and cost-containment strategies, are increasing the demand for portable, user-friendly syringe pumps for safe medication delivery outside hospitals. Favorable regulatory environments and reimbursement policies further support the sustained growth and innovation within the America Syringe Infusion Pumps Market Report Highlights: Pediatrics/neonatology held the largest revenue share of over 25% in 2024, owing to the critical need for precise drug delivery for newborns and infants, coupled with advancements in safety technologies and NICU/PICU investments The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period Market growth is fueled by the critical need for precise syringe pump delivery of potent drugs, supported by safety features, and the increasing number of cancer cases. Hospitals dominated the market with around 40.0% of the total revenue share in 2024 due to high demand for precise drug delivery in critical care and diverse applications. Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period. The U.S. dominated the North American syringe infusion pumps market, supported by the high prevalence of chronic diseases and growing national healthcare expenditure. Companies Featured The major companies featured in this North America Syringe Infusion Pumps market report include: Baxter B. Braun Medical Inc. Fresenius Kabi AG ICU Medical, Inc. Micrel Medical Devices SA Boston Scientific Corporation BD Terumo Corporation Moog Inc. IRadimed Corporation CODAN Companies ACROMED Key Attributes: Report Attribute Details No. of Pages 80 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $645.1 Million Forecasted Market Value (USD) by 2030 $1040 Million Compound Annual Growth Rate 8.4% Regions Covered North America Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. North America Syringe Infusion Pumps Market Variables, Trends & Scope3.1. Market Lineage Outlook3.2. Market Dynamics3.3. North America Syringe Infusion Pumps Market Analysis Tools3.3.1. Industry Analysis - Porter's3.3.2. PESTEL AnalysisChapter 4. North America Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis4.1. Disease Indication Segment Dashboard4.2. North America Syringe Infusion Pumps Market: Disease Indication Movement Analysis4.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)4.4. Chemotherapy4.5. Diabetes4.6. Gastroenterology4.7. Analgesia/Pain Management4.8. Pediatrics/Neonatology4.9. Hematology4.10. OthersChapter 5. North America Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis5.1. End Use Segment Dashboard5.2. North America Syringe Infusion Pumps Market: End Use Movement Analysis5.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)5.4. Hospitals5.5. Homecare5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)Chapter 6. North America Syringe Infusion Pumps Market: Country Estimates & Trend Analysis6.1. Country Market Dashboard6.2. Country Market Share Analysis, 2024 & 20306.3. North America Syringe Infusion Pumps Market by country: Key Takeaways6.4. U.S.6.5. Canada6.6. MexicoChapter 7. Competitive Landscape7.1. Recent Developments & Impact Analysis, By Key Market Participants7.2. Company/Competition Categorization7.3. Vendor Landscape7.3.1. Key company heat map analysis, 20247.4. Company Profiles Baxter B. Braun Medical Inc. Fresenius Kabi AG ICU Medical, Inc. Micrel Medical Devices SA Boston Scientific Corporation BD Terumo Corporation Moog Inc. IRadimed Corporation CODAN Companies ACROMED For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Syringe Infusion Pumps Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Complementary and Alternative Medicine Market Competitive Landscape 2025, with Gaia Herbs, Herb Pharm, Pure Encapsulations, NOW Health Group, Nature's Way, Solgar, Twinlab, Ayush Herbs, and more
U.S. Complementary and Alternative Medicine Market Competitive Landscape 2025, with Gaia Herbs, Herb Pharm, Pure Encapsulations, NOW Health Group, Nature's Way, Solgar, Twinlab, Ayush Herbs, and more

Yahoo

timean hour ago

  • Yahoo

U.S. Complementary and Alternative Medicine Market Competitive Landscape 2025, with Gaia Herbs, Herb Pharm, Pure Encapsulations, NOW Health Group, Nature's Way, Solgar, Twinlab, Ayush Herbs, and more

The U.S. Complementary and Alternative Medicine Market offers significant growth opportunities, driven by increased consumer interest in wellness and non-traditional medicine. Key trends include integration with conventional healthcare, rising chronic and stress-related health issues, and mainstream acceptance of therapies like herbal supplements and mindfulness practices. However, challenges such as regulatory inconsistencies and quality control issues remain. U.S. Complementary and Alternative Medicine Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "United States Complementary and Alternative Medicine Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to United States Complementary and Alternative Medicine Market was valued at USD 34.82 Billion in 2024, and is expected to reach USD 125.94 Billion by 2030, rising at a CAGR of 23.87%. The market is expanding rapidly as consumer interest in wellness-oriented lifestyles grows and individuals increasingly explore treatment options beyond traditional medicine. Therapies like acupuncture, homeopathy, naturopathy, energy healing, and aromatherapy are gaining traction across diverse demographics for managing both acute and chronic health concerns. CAM offerings are increasingly integrated with fitness memberships, corporate wellness programs, and digital health subscriptions, contributing to their mainstream acceptance. The popularity of herbal infusions, detox products, and plant-based diets further reflects a cultural pivot toward natural health solutions. According to the NCCIH's 2023 survey, approximately 40% of American adults and 12% of children use complementary therapies. CAM services are being widely incorporated into holistic clinics, hospitals, and telehealth platforms, covering modalities such as yoga, mindfulness, chiropractic care, and herbal supplementation. The younger population is adopting Reiki, sound healing, and crystal therapy, while older adults seek non-invasive methods for pain and sleep disorders. CAM visibility is amplified by wearable health tech, social media influencers, and expanded retail presence in pharmacies and online marketplaces. Key Market Drivers Increase in Chronic and Stress-Related Health Conditions The growing incidence of chronic and stress-induced health conditions is a key driver of the United States Complementary and Alternative Medicine Market. Chronic diseases like cardiovascular disorders, diabetes, arthritis, and respiratory ailments continue to rise, affecting a significant portion of the U.S. population. As of 2023, CDC data shows 6 in 10 U.S. adults live with at least one chronic condition, and 4 in 10 have two or more. Patients are increasingly turning to CAM therapies for their holistic and less invasive approach to long-term disease management. Stress-related issues are also prevalent due to modern lifestyle demands. The American Psychological Association reported that 77% of Americans frequently experience physical symptoms from stress, and 73% report psychological effects. CAM practices such as meditation, acupuncture, herbal therapy, and mindfulness are gaining popularity as non-drug alternatives for mental and emotional well-being. Clinicians are recognizing the value of integrative care models that blend conventional and complementary therapies to address both physical and emotional dimensions of health. The rising emphasis on self-care, wellness, and preventive strategies is further fueling CAM's appeal. Key Market Challenges Lack of Standardized Regulations and Quality Control One of the most significant challenges facing the U.S. CAM market is the lack of consistent regulatory frameworks and standardized quality controls. Unlike conventional pharmaceuticals, many CAM products - including herbal supplements and traditional remedies - do not undergo uniform evaluation for safety and efficacy. This regulatory inconsistency creates uncertainty for both consumers and manufacturers, limiting broader adoption and integration into mainstream healthcare. Quality assurance is another critical issue. Variability in ingredient sourcing, formulation, and production processes leads to inconsistent product quality and therapeutic outcomes. Botanical components, for example, can vary significantly in potency depending on region, harvesting practices, and processing methods. These inconsistencies raise concerns about contamination and mislabeling. The absence of robust quality standards can reduce consumer trust and expose producers to legal risks. The lack of regulatory clarity also discourages investment and innovation, delaying the development of validated, evidence-based CAM solutions. Key Market Trends Integration of CAM into Conventional Healthcare Systems A prominent trend in the U.S. CAM market is its growing integration into mainstream healthcare settings. The Department of Veterans Affairs has significantly expanded its use of Complementary and Integrative Health (CIH) practices to support pain management, mental health, and overall well-being. This move represents a broader push toward patient-centered care that includes both medical and holistic treatment options. Government-backed initiatives further reflect this integration. For instance, in 2023, the Department of Health and Human Services launched a national strategy emphasizing Food Is Medicine (FIM) programs, aligning with CAM's foundational principles. These developments signal increasing institutional support for CAM therapies as part of broader healthcare delivery models. Hospitals, insurers, and public health organizations are recognizing the value of non-invasive, cost-effective interventions in managing chronic diseases and improving patient satisfaction. This institutional adoption is expected to accelerate as more clinical data validates CAM's efficacy and safety. Key Market Players Gaia Herbs, Inc. Herb Pharm, LLC Pure Encapsulations, LLC NOW Health Group, Inc. Nature's Way Products, LLC Solgar, Inc. Traditional Medicinals, Inc. Twinlab Consolidated Holdings, Inc. Ayush Herbs, Inc. Integrative Therapeutics Key Attributes: Report Attribute Details No. of Pages 84 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $34.82 Billion Forecasted Market Value (USD) by 2030 $125.94 Billion Compound Annual Growth Rate 23.8% Regions Covered United States Report Scope: In this report, the United States Complementary and Alternative Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: United States Complementary and Alternative Medicine Market, By Intervention: Traditional Alternative Medicine/Botanicals Mind Healing Body Healing External Energy Aromatherapy United States Complementary and Alternative Medicine Market, By Distribution Method: Direct Sales E-sales Distance Correspondence United States Complementary and Alternative Medicine Market, By Region: North-East Mid-West West South For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Complementary and Alternative Medicine Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio

The Number-1 Food to Help Reduce Your Risk of Stroke, According to Dietitians
The Number-1 Food to Help Reduce Your Risk of Stroke, According to Dietitians

Yahoo

timean hour ago

  • Yahoo

The Number-1 Food to Help Reduce Your Risk of Stroke, According to Dietitians

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." About 795,000 people in the U.S. experience a stroke each year, which can be a life-altering experience. While you can't influence some risk factors like your age or your genetics, there are lifestyle tweaks you can make to help. That includes making diet tweaks by adding foods that may help lower your risk of stroke. Overall, following a healthy eating pattern can help lower a slew of stroke risk factors, including your blood pressure, cholesterol, and blood sugar regulation, says Cheng-Han Chen, M.D., interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center in Laguna Hills, CA. Meet the experts: Scott Keatley, R.D., co-owner of Keatley Medical Nutrition Therapy; Keri Gans, R.D.N., dietitian and host of The Keri Report podcast; Sonya Angelone, R.D.N., is a nutritionist and registered dietitian based in San Francisco, California; Kristine Dilley, R.D.N, a nutritionist at The Ohio State University Wexner Medical Center; Cheng-Han Chen, M.D., interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center in Laguna Hills, CA There are specific diets linked to a lower risk of stroke: the DASH diet and Mediterranean diet. 'These dietary patterns are similar in that they both encourage increasing your intake of plant-based foods such as vegetables, fruits, whole grains, beans and legumes; lean meats, fish, low-fat dairy, and heart healthy fats such as olive oil,' says Kristine Dilley, R.D.N, a nutritionist at The Ohio State University Wexner Medical Center. 'In addition to the nutritional benefits of these diets, they are also generally lower in calorie density which may aid in weight loss. Even relatively small decreases in weight can significantly improve your risk.' Certain nutrients may be more helpful than others, though. 'Diets rich in anti-inflammatory [foods] and nutrients that keep your veins and vessels nice and open—like potassium, omega-3s, polyphenols, and magnesium—can lower blood pressure, improve artery flexibility, and reduce clotting, all of which significantly reduce the risk of both ischemic and hemorrhagic strokes,' says Scott Keatley, R.D., co-owner of Keatley Medical Nutrition Therapy. It's also important to limit certain things if you're worried about your stroke risk. 'Having a balanced diet lower in saturated fat, lower in sugar, and lower in processed foods will all be helpful,' Dr. Chen says. While focusing on an overall healthy diet is important, it's fair to wonder if certain foods are better for reducing your stroke risk than others. With that in mind, these are the biggest foods dietitians and a cardiologist recommend focusing on to lower your stroke risk. While Dr. Chen says you can't go wrong focusing on fruits, vegetables, nuts, whole grains, and lean proteins, some foods may be more powerful for lowering your risk of stroke than others. These are the biggies, according to experts. Think: Spinach, kale, and arugula. These are a top choice of Sonya Angelone, R.D.N., a nutritionist and registered dietitian based in San Francisco, California. 'Green leafy vegetables can lower stroke risk because of their high content of nitrates,' she says. 'The body converts nitrates into nitric oxide, which can help relax the pressure in arteries, promote healthy blood flow, and reduce blood pressure.' A study published in the European Journal of Epidemiology in 2021 found a link between people who had at least 60 milligrams a day of nitrates from vegetables and a 17% lower risk of stroke. (That's equal to about a cup of leafy green vegetables.) Leafy greens are also rich in vitamin K, which helps regulate clotting, Keatley says. 'They also have vitamins, minerals, and fiber which are associated with a lower stroke risk,' Angelone says. Citrus fruits like oranges and grapefruit contain vitamin C, folate, and potassium, which have antioxidant and anti-inflammatory properties, Dilley says. These also contain soluble fiber, which can help lower your cholesterol (another stroke risk factor). Just be aware that grapefruit can interfere with certain medications, so Angelone warns that it's best to check in with your healthcare provider to make sure you're not taking anything that may interact with the fruit. Walnuts have repeatedly been flagged as a food that's friendly to your cardiovascular system. One study published in the journal Circulation in 2021found that eating about a ½ cup a day of walnuts for two years lowered levels of LDL ('bad') cholesterol. (High levels of LDL cholesterol are a risk factor for stroke.) The big allure of walnuts is their omega-3 fatty acid content. 'This may support heart health and reduce inflammation in the body,' says Keri Gans, R.D.N., dietitian and host of The Keri Report podcast. 'They are a good source of alpha linolenic acid, a type of omega-3 fatty acid,' Angelone says. 'This has been shown to reduce inflammation, improve blood flow, and lower blood pressure.' Walnuts are also packed with antioxidants and other nutrients that are protective for your cardiovascular system, she says. 'Yogurt offers calcium, potassium, and probiotics, which contribute to lower blood pressure and better lipid balance, particularly when it replaces processed or sugary snacks,' Keatley says. Something else to consider, per Angelone: Yogurt is considered part of the DASH diet, which is also great for stroke prevention. Just aim for low-sugar options, since Dr. Chen points out that added sugar can raise your risk of cardiovascular disease. Whole grains like oats are packed with magnesium, B-vitamins, and antioxidants to protect your vascular health, Keatley says. 'They also contribute fiber that promotes steady blood sugar,' he says. Whole grains may also help tamp down on bodily inflammation, further lowering your stroke risk, Angelone says. Fatty fish like salmon, sardines, and mackerel are rich in EPA and DHA, Keatley points out. 'These reduce inflammation, stabilize heart rhythm, improve lipid profiles, and make platelets less sticky, thus reducing clot risk,' he says. Fatty fish can also help to lower your blood pressure and cholesterol, which are major risk factors for stroke, Angelone says. One more thing to consider, per Dilley: Fatty fish are a lean source of protein, which can help with weight management, and excess weight is linked with a higher risk of stroke. Soluble fiber retains water and turns into a gel in your GI tract, slowing digestion. Foods rich in soluble fiber lower LDL cholesterol and help manage blood sugar spikes that can damage your blood vessels, Keatley says. There are a bunch of foods that fall into this category, but Dilley says these are some of the best: Apples Apricots Figs Pears Carrots Broccoli Sweet potatoes While Dr. Chen recommends that his patients have lean proteins, he says he specifically encourages plant-based proteins. Research published in The American Journal of Clinical Nutrition in 2024 found that, compared to people who ate high levels of animal protein, people who ate plant-based protein had a 19% lower risk of cardiovascular disease and a 27% lower risk of coronary heart disease. 'Beans such as black beans and kidney beans are a nutritional powerhouse in that they supply both soluble fiber and a healthy serving of plant-based protein at meals,' Dilley says. 'Increasing intake of plant-based proteins allows you to decrease intake of some animal-based foods that may be higher in saturated fat.' The foods we just mentioned are the biggest ones flagged by dietitians and Dr. Chen, but experts say these are also worth adding to your dietary rotation: Coffee. 'The chemical compounds in coffee, including trace minerals and phenolic compounds, act as antioxidants and may have a beneficial effect on cholesterol levels, oxidation, and inflammation,' Angelone says. 'So, drinking moderate amounts of coffee, including decaf, may help decrease risk for stroke.' Beets. 'These are also nitrate-rich and support nitric oxide production,' Keatley says. Avocados. These fruits 'provide potassium and heart-healthy monounsaturated fats,' according to Keatley. Green tea. Rich in catechins that reduce oxidative stress, sipping green tea may help lower your stroke risk, Keatley says. Legumes. These powerhouse plants 'supply plant-based protein and fiber,' Keatley points out. Dark chocolate. The flavonoids found in dark chocolate 'improve nitric oxide bioavailability and may modestly reduce blood pressure,' Keatley says. (Just eat this in moderation, of course.) If you're especially concerned with your stroke risk, Dr. Chen says it's important to talk to a healthcare provider. They can walk you through your personal risk factors, as well as what you can do to lower your risk. You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store